Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery (NCT07234292) | Clinical Trial Compass
RecruitingNot Applicable
Evaluation of Patient Satisfaction With Blephaderm as a Complementary Care in Post-eyelid Surgery
France30 participantsStarted 2025-10-30
Plain-language summary
The goal of this non-interventional, open and monocentric study is to evaluate the satisfaction of 30 patients, after 3 months with Blephaderm eyelid cream, as a complementary care in post-eyelid surgery (Blepharopasty or ptosis).
The participant will be asked to use Blephaderm twice a day. The patient satisfaction will be evaluated using a VAS scale.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years old
* Patients planning a blepharoplasty or a ptosis surgery in at least one eye.
* Patient affiliated to a health social security system
* Female of childbearing potential should use a medically accepted contraceptive regimen since at least 12 weeks before the beginning of the study, during all the study and at least 1 month after the study end.
Exclusion Criteria:
In terms of population:
* Pregnant or nursing woman or planning a pregnancy during the study.
* Patient who had been deprived of their freedom by administrative or legal decision
* Minor patient.
* Major patient who is under guardianship or who is not able to express his non opposition.
* Patient suspected to be non-compliant according to the investigator's judgment.
* Patient enrolled in another clinical trial or which exclusion period is not over.
In terms of associated pathology
* Patient with a history or active systemic condition or receiving a medication which, in the investigator's judgment, put the patient at undue risk.
* Patient suffering from a severe or progressive disease.
* Patient with known or suspected hypersensitivity to one of the components of the product.
Related to previous or ongoing treatment
* Patient undergoing a topical treatment on the test area or a systemic treatment.
* Patient under a long-term corticosteroid, NSAID or HIV therapy at the investigator appreciation.
* Patient under immunosuppressive therapy
* Patient under bisphosphonate the…
What they're measuring
1
global satisfaction of the patient on eyelid comfort after 3 months of Bllephaderm® use, assessed at M4, using a VAS from 0 (unsatisfied) to 10 (very satisfied).